Intra-Cellular Therapies is a biopharmaceutical company founded on Dr. Paul Greengard’s Nobel Prize - winning research that uncovered how therapies affect the inner-working of cells in the body.
We leverage this intracellular approach to develop and deliver innovative treatments for people living with complex psychiatric, neurologic, and other diseases.